nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurbiprofen—PTGS1—esophageal cancer	0.316	0.636	CbGaD
Flurbiprofen—PTGS2—esophageal cancer	0.181	0.364	CbGaD
Flurbiprofen—ABCC4—Methotrexate—esophageal cancer	0.0626	0.275	CbGbCtD
Flurbiprofen—PTGS2—Cisplatin—esophageal cancer	0.0566	0.249	CbGbCtD
Flurbiprofen—CYP2C9—Capecitabine—esophageal cancer	0.0382	0.168	CbGbCtD
Flurbiprofen—SLC22A6—Methotrexate—esophageal cancer	0.0272	0.12	CbGbCtD
Flurbiprofen—ALB—Methotrexate—esophageal cancer	0.0232	0.102	CbGbCtD
Flurbiprofen—UGT2B4—pericardium—esophageal cancer	0.0208	0.528	CbGeAlD
Flurbiprofen—CYP2C9—Cisplatin—esophageal cancer	0.0193	0.0848	CbGbCtD
Flurbiprofen—UGT1A3—digestive system—esophageal cancer	0.00241	0.0613	CbGeAlD
Flurbiprofen—UGT2B4—lung—esophageal cancer	0.0021	0.0534	CbGeAlD
Flurbiprofen—UGT1A9—digestive system—esophageal cancer	0.00172	0.0437	CbGeAlD
Flurbiprofen—UGT2B7—digestive system—esophageal cancer	0.00139	0.0352	CbGeAlD
Flurbiprofen—UGT1A1—digestive system—esophageal cancer	0.00118	0.0299	CbGeAlD
Flurbiprofen—ABCC4—bronchus—esophageal cancer	0.000995	0.0253	CbGeAlD
Flurbiprofen—ABCC4—digestive system—esophageal cancer	0.000768	0.0195	CbGeAlD
Flurbiprofen—ABCC4—lung—esophageal cancer	0.000642	0.0163	CbGeAlD
Flurbiprofen—PTGS1—epithelium—esophageal cancer	0.000595	0.0151	CbGeAlD
Flurbiprofen—PTGS1—smooth muscle tissue—esophageal cancer	0.000573	0.0145	CbGeAlD
Flurbiprofen—PTGS2—epithelium—esophageal cancer	0.000568	0.0144	CbGeAlD
Flurbiprofen—PTGS2—bronchus—esophageal cancer	0.00056	0.0142	CbGeAlD
Flurbiprofen—PTGS2—smooth muscle tissue—esophageal cancer	0.000548	0.0139	CbGeAlD
Flurbiprofen—PTGS1—trachea—esophageal cancer	0.000526	0.0134	CbGeAlD
Flurbiprofen—PTGS2—trachea—esophageal cancer	0.000503	0.0128	CbGeAlD
Flurbiprofen—CYP2C9—digestive system—esophageal cancer	0.000496	0.0126	CbGeAlD
Flurbiprofen—Carprofen—PTGS1—esophageal cancer	0.000474	0.078	CrCbGaD
Flurbiprofen—ALB—lymph node—esophageal cancer	0.000453	0.0115	CbGeAlD
Flurbiprofen—PTGS1—digestive system—esophageal cancer	0.000452	0.0115	CbGeAlD
Flurbiprofen—ABCC4—lymph node—esophageal cancer	0.000439	0.0111	CbGeAlD
Flurbiprofen—PTGS2—digestive system—esophageal cancer	0.000432	0.011	CbGeAlD
Flurbiprofen—Tiaprofenic acid—PTGS1—esophageal cancer	0.000386	0.0636	CrCbGaD
Flurbiprofen—PTGS1—lung—esophageal cancer	0.000378	0.00959	CbGeAlD
Flurbiprofen—PTGS2—lung—esophageal cancer	0.000361	0.00917	CbGeAlD
Flurbiprofen—Gastroenteritis—Capecitabine—esophageal cancer	0.000361	0.00324	CcSEcCtD
Flurbiprofen—Abdominal discomfort—Cisplatin—esophageal cancer	0.000359	0.00323	CcSEcCtD
Flurbiprofen—Ibuprofen—BCL2—esophageal cancer	0.000358	0.059	CrCbGaD
Flurbiprofen—Deafness—Capecitabine—esophageal cancer	0.000357	0.00321	CcSEcCtD
Flurbiprofen—Vascular purpura—Capecitabine—esophageal cancer	0.000357	0.00321	CcSEcCtD
Flurbiprofen—Pancytopenia—Cisplatin—esophageal cancer	0.000356	0.0032	CcSEcCtD
Flurbiprofen—Glossitis—Methotrexate—esophageal cancer	0.000356	0.0032	CcSEcCtD
Flurbiprofen—Herpes simplex—Methotrexate—esophageal cancer	0.000356	0.0032	CcSEcCtD
Flurbiprofen—Oliguria—Methotrexate—esophageal cancer	0.000356	0.0032	CcSEcCtD
Flurbiprofen—Hepatic failure—Capecitabine—esophageal cancer	0.000356	0.0032	CcSEcCtD
Flurbiprofen—Haemolytic anaemia—Capecitabine—esophageal cancer	0.000354	0.00318	CcSEcCtD
Flurbiprofen—Hyperuricaemia—Methotrexate—esophageal cancer	0.000353	0.00318	CcSEcCtD
Flurbiprofen—Fenbufen—PTGS1—esophageal cancer	0.000351	0.0579	CrCbGaD
Flurbiprofen—Hepatic enzyme increased—Methotrexate—esophageal cancer	0.000347	0.00312	CcSEcCtD
Flurbiprofen—Ulcer—Methotrexate—esophageal cancer	0.000347	0.00312	CcSEcCtD
Flurbiprofen—Libido decreased—Capecitabine—esophageal cancer	0.000345	0.0031	CcSEcCtD
Flurbiprofen—Increased appetite—Capecitabine—esophageal cancer	0.00034	0.00306	CcSEcCtD
Flurbiprofen—Amnesia—Capecitabine—esophageal cancer	0.00034	0.00306	CcSEcCtD
Flurbiprofen—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.000339	0.00305	CcSEcCtD
Flurbiprofen—Diflunisal—PTGS1—esophageal cancer	0.000338	0.0556	CrCbGaD
Flurbiprofen—Thirst—Capecitabine—esophageal cancer	0.000336	0.00302	CcSEcCtD
Flurbiprofen—Renal impairment—Capecitabine—esophageal cancer	0.000336	0.00302	CcSEcCtD
Flurbiprofen—Vasculitis—Methotrexate—esophageal cancer	0.000336	0.00302	CcSEcCtD
Flurbiprofen—Blood uric acid increased—Methotrexate—esophageal cancer	0.000334	0.003	CcSEcCtD
Flurbiprofen—Purpura—Capecitabine—esophageal cancer	0.000332	0.00298	CcSEcCtD
Flurbiprofen—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00033	0.00296	CcSEcCtD
Flurbiprofen—Arthritis—Capecitabine—esophageal cancer	0.000329	0.00296	CcSEcCtD
Flurbiprofen—Renal failure—Cisplatin—esophageal cancer	0.000329	0.00295	CcSEcCtD
Flurbiprofen—Vaginal inflammation—Methotrexate—esophageal cancer	0.000328	0.00295	CcSEcCtD
Flurbiprofen—Pulmonary embolism—Methotrexate—esophageal cancer	0.000328	0.00295	CcSEcCtD
Flurbiprofen—Myocardial infarction—Cisplatin—esophageal cancer	0.000328	0.00295	CcSEcCtD
Flurbiprofen—Cerebrovascular accident—Capecitabine—esophageal cancer	0.000326	0.00293	CcSEcCtD
Flurbiprofen—Stomatitis—Cisplatin—esophageal cancer	0.000326	0.00293	CcSEcCtD
Flurbiprofen—Conjunctivitis—Cisplatin—esophageal cancer	0.000325	0.00292	CcSEcCtD
Flurbiprofen—Cystitis noninfective—Methotrexate—esophageal cancer	0.00032	0.00288	CcSEcCtD
Flurbiprofen—Melaena—Methotrexate—esophageal cancer	0.00032	0.00288	CcSEcCtD
Flurbiprofen—Osteoarthritis—Capecitabine—esophageal cancer	0.00032	0.00287	CcSEcCtD
Flurbiprofen—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.00032	0.00287	CcSEcCtD
Flurbiprofen—Diplopia—Capecitabine—esophageal cancer	0.00032	0.00287	CcSEcCtD
Flurbiprofen—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.000317	0.00285	CcSEcCtD
Flurbiprofen—Cystitis—Methotrexate—esophageal cancer	0.000317	0.00285	CcSEcCtD
Flurbiprofen—Migraine—Capecitabine—esophageal cancer	0.000315	0.00283	CcSEcCtD
Flurbiprofen—Skin exfoliation—Methotrexate—esophageal cancer	0.000313	0.00281	CcSEcCtD
Flurbiprofen—Vaginal infection—Methotrexate—esophageal cancer	0.00031	0.00278	CcSEcCtD
Flurbiprofen—Aplastic anaemia—Methotrexate—esophageal cancer	0.000308	0.00277	CcSEcCtD
Flurbiprofen—Oxaprozin—PTGS1—esophageal cancer	0.000305	0.0503	CrCbGaD
Flurbiprofen—Salsalate—PTGS1—esophageal cancer	0.000305	0.0503	CrCbGaD
Flurbiprofen—Mood swings—Capecitabine—esophageal cancer	0.000303	0.00272	CcSEcCtD
Flurbiprofen—Ataxia—Capecitabine—esophageal cancer	0.000301	0.0027	CcSEcCtD
Flurbiprofen—Coma—Methotrexate—esophageal cancer	0.0003	0.00269	CcSEcCtD
Flurbiprofen—Ecchymosis—Methotrexate—esophageal cancer	0.000296	0.00267	CcSEcCtD
Flurbiprofen—Urine output increased—Methotrexate—esophageal cancer	0.000296	0.00267	CcSEcCtD
Flurbiprofen—Bladder pain—Methotrexate—esophageal cancer	0.000296	0.00267	CcSEcCtD
Flurbiprofen—Dry skin—Capecitabine—esophageal cancer	0.000293	0.00264	CcSEcCtD
Flurbiprofen—Suprofen—PTGS1—esophageal cancer	0.000293	0.0482	CrCbGaD
Flurbiprofen—Visual impairment—Cisplatin—esophageal cancer	0.000289	0.0026	CcSEcCtD
Flurbiprofen—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000288	0.00259	CcSEcCtD
Flurbiprofen—Sepsis—Methotrexate—esophageal cancer	0.000285	0.00256	CcSEcCtD
Flurbiprofen—Gastritis—Capecitabine—esophageal cancer	0.000283	0.00254	CcSEcCtD
Flurbiprofen—Muscular weakness—Capecitabine—esophageal cancer	0.000282	0.00254	CcSEcCtD
Flurbiprofen—Tinnitus—Cisplatin—esophageal cancer	0.00028	0.00252	CcSEcCtD
Flurbiprofen—Lymphadenopathy—Methotrexate—esophageal cancer	0.000279	0.00251	CcSEcCtD
Flurbiprofen—Abdominal distension—Capecitabine—esophageal cancer	0.000278	0.0025	CcSEcCtD
Flurbiprofen—Influenza—Capecitabine—esophageal cancer	0.000276	0.00248	CcSEcCtD
Flurbiprofen—Asthma—Capecitabine—esophageal cancer	0.000276	0.00248	CcSEcCtD
Flurbiprofen—Polyuria—Methotrexate—esophageal cancer	0.000271	0.00244	CcSEcCtD
Flurbiprofen—Photosensitivity—Methotrexate—esophageal cancer	0.000271	0.00244	CcSEcCtD
Flurbiprofen—Carprofen—PTGS2—esophageal cancer	0.000271	0.0446	CrCbGaD
Flurbiprofen—Angina pectoris—Capecitabine—esophageal cancer	0.000269	0.00242	CcSEcCtD
Flurbiprofen—Arrhythmia—Cisplatin—esophageal cancer	0.000268	0.00241	CcSEcCtD
Flurbiprofen—Bronchitis—Capecitabine—esophageal cancer	0.000266	0.00239	CcSEcCtD
Flurbiprofen—Alopecia—Cisplatin—esophageal cancer	0.000265	0.00238	CcSEcCtD
Flurbiprofen—Abdominal discomfort—Capecitabine—esophageal cancer	0.000265	0.00238	CcSEcCtD
Flurbiprofen—Hepatic failure—Methotrexate—esophageal cancer	0.000265	0.00238	CcSEcCtD
Flurbiprofen—Pancytopenia—Capecitabine—esophageal cancer	0.000262	0.00236	CcSEcCtD
Flurbiprofen—Neutropenia—Capecitabine—esophageal cancer	0.000258	0.00232	CcSEcCtD
Flurbiprofen—Dysuria—Capecitabine—esophageal cancer	0.000258	0.00232	CcSEcCtD
Flurbiprofen—PTGS1—lymph node—esophageal cancer	0.000258	0.00656	CbGeAlD
Flurbiprofen—Flatulence—Cisplatin—esophageal cancer	0.000257	0.00231	CcSEcCtD
Flurbiprofen—Fenoprofen—PTGS1—esophageal cancer	0.000252	0.0416	CrCbGaD
Flurbiprofen—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000252	0.00227	CcSEcCtD
Flurbiprofen—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000252	0.00227	CcSEcCtD
Flurbiprofen—Hyperglycaemia—Capecitabine—esophageal cancer	0.000249	0.00224	CcSEcCtD
Flurbiprofen—Pneumonia—Capecitabine—esophageal cancer	0.000248	0.00223	CcSEcCtD
Flurbiprofen—PTGS2—lymph node—esophageal cancer	0.000247	0.00627	CbGeAlD
Flurbiprofen—Tremor—Cisplatin—esophageal cancer	0.000245	0.0022	CcSEcCtD
Flurbiprofen—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000244	0.0022	CcSEcCtD
Flurbiprofen—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000243	0.00218	CcSEcCtD
Flurbiprofen—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000243	0.00218	CcSEcCtD
Flurbiprofen—Ill-defined disorder—Cisplatin—esophageal cancer	0.000242	0.00218	CcSEcCtD
Flurbiprofen—Renal failure—Capecitabine—esophageal cancer	0.000242	0.00218	CcSEcCtD
Flurbiprofen—Myocardial infarction—Capecitabine—esophageal cancer	0.000242	0.00217	CcSEcCtD
Flurbiprofen—Anaemia—Cisplatin—esophageal cancer	0.000241	0.00217	CcSEcCtD
Flurbiprofen—Stomatitis—Capecitabine—esophageal cancer	0.00024	0.00216	CcSEcCtD
Flurbiprofen—Jaundice—Capecitabine—esophageal cancer	0.00024	0.00216	CcSEcCtD
Flurbiprofen—Conjunctivitis—Capecitabine—esophageal cancer	0.00024	0.00215	CcSEcCtD
Flurbiprofen—Urinary tract infection—Capecitabine—esophageal cancer	0.00024	0.00215	CcSEcCtD
Flurbiprofen—Osteoarthritis—Methotrexate—esophageal cancer	0.000238	0.00214	CcSEcCtD
Flurbiprofen—Malaise—Cisplatin—esophageal cancer	0.000236	0.00212	CcSEcCtD
Flurbiprofen—Haematuria—Capecitabine—esophageal cancer	0.000235	0.00211	CcSEcCtD
Flurbiprofen—Mefenamic acid—PTGS1—esophageal cancer	0.000234	0.0385	CrCbGaD
Flurbiprofen—Leukopenia—Cisplatin—esophageal cancer	0.000234	0.0021	CcSEcCtD
Flurbiprofen—Epistaxis—Capecitabine—esophageal cancer	0.000232	0.00209	CcSEcCtD
Flurbiprofen—Agranulocytosis—Capecitabine—esophageal cancer	0.00023	0.00207	CcSEcCtD
Flurbiprofen—Naproxen—PTGS1—esophageal cancer	0.00023	0.0378	CrCbGaD
Flurbiprofen—Convulsion—Cisplatin—esophageal cancer	0.000226	0.00203	CcSEcCtD
Flurbiprofen—Mood swings—Methotrexate—esophageal cancer	0.000225	0.00203	CcSEcCtD
Flurbiprofen—Ataxia—Methotrexate—esophageal cancer	0.000224	0.00201	CcSEcCtD
Flurbiprofen—Myalgia—Cisplatin—esophageal cancer	0.000222	0.002	CcSEcCtD
Flurbiprofen—Haemoglobin—Capecitabine—esophageal cancer	0.000222	0.002	CcSEcCtD
Flurbiprofen—Rhinitis—Capecitabine—esophageal cancer	0.000222	0.00199	CcSEcCtD
Flurbiprofen—Anxiety—Cisplatin—esophageal cancer	0.000222	0.00199	CcSEcCtD
Flurbiprofen—Hepatitis—Capecitabine—esophageal cancer	0.000221	0.00199	CcSEcCtD
Flurbiprofen—Haemorrhage—Capecitabine—esophageal cancer	0.000221	0.00199	CcSEcCtD
Flurbiprofen—Tiaprofenic acid—PTGS2—esophageal cancer	0.000221	0.0364	CrCbGaD
Flurbiprofen—Discomfort—Cisplatin—esophageal cancer	0.00022	0.00198	CcSEcCtD
Flurbiprofen—Pharyngitis—Capecitabine—esophageal cancer	0.00022	0.00197	CcSEcCtD
Flurbiprofen—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000214	0.00193	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Cisplatin—esophageal cancer	0.000213	0.00192	CcSEcCtD
Flurbiprofen—Oedema—Cisplatin—esophageal cancer	0.000213	0.00192	CcSEcCtD
Flurbiprofen—Visual impairment—Capecitabine—esophageal cancer	0.000213	0.00192	CcSEcCtD
Flurbiprofen—Infection—Cisplatin—esophageal cancer	0.000212	0.0019	CcSEcCtD
Flurbiprofen—Erythema multiforme—Capecitabine—esophageal cancer	0.000209	0.00188	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Cisplatin—esophageal cancer	0.000209	0.00188	CcSEcCtD
Flurbiprofen—Tachycardia—Cisplatin—esophageal cancer	0.000208	0.00187	CcSEcCtD
Flurbiprofen—Tinnitus—Capecitabine—esophageal cancer	0.000206	0.00185	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Cisplatin—esophageal cancer	0.000206	0.00185	CcSEcCtD
Flurbiprofen—Asthma—Methotrexate—esophageal cancer	0.000206	0.00185	CcSEcCtD
Flurbiprofen—Eosinophilia—Methotrexate—esophageal cancer	0.000204	0.00183	CcSEcCtD
Flurbiprofen—Anorexia—Cisplatin—esophageal cancer	0.000203	0.00183	CcSEcCtD
Flurbiprofen—Pancreatitis—Methotrexate—esophageal cancer	0.000202	0.00181	CcSEcCtD
Flurbiprofen—Fenbufen—PTGS2—esophageal cancer	0.000201	0.0331	CrCbGaD
Flurbiprofen—Angiopathy—Capecitabine—esophageal cancer	0.000201	0.0018	CcSEcCtD
Flurbiprofen—Hypotension—Cisplatin—esophageal cancer	0.000199	0.00179	CcSEcCtD
Flurbiprofen—Chills—Capecitabine—esophageal cancer	0.000198	0.00178	CcSEcCtD
Flurbiprofen—Arrhythmia—Capecitabine—esophageal cancer	0.000198	0.00178	CcSEcCtD
Flurbiprofen—Abdominal discomfort—Methotrexate—esophageal cancer	0.000197	0.00177	CcSEcCtD
Flurbiprofen—Alopecia—Capecitabine—esophageal cancer	0.000195	0.00176	CcSEcCtD
Flurbiprofen—Pancytopenia—Methotrexate—esophageal cancer	0.000195	0.00176	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000194	0.00175	CcSEcCtD
Flurbiprofen—Diflunisal—PTGS2—esophageal cancer	0.000193	0.0318	CrCbGaD
Flurbiprofen—Neutropenia—Methotrexate—esophageal cancer	0.000192	0.00173	CcSEcCtD
Flurbiprofen—Dysuria—Methotrexate—esophageal cancer	0.000192	0.00173	CcSEcCtD
Flurbiprofen—Paraesthesia—Cisplatin—esophageal cancer	0.000191	0.00172	CcSEcCtD
Flurbiprofen—Dyspnoea—Cisplatin—esophageal cancer	0.00019	0.00171	CcSEcCtD
Flurbiprofen—Flatulence—Capecitabine—esophageal cancer	0.00019	0.00171	CcSEcCtD
Flurbiprofen—Erectile dysfunction—Methotrexate—esophageal cancer	0.000189	0.0017	CcSEcCtD
Flurbiprofen—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000188	0.00169	CcSEcCtD
Flurbiprofen—Decreased appetite—Cisplatin—esophageal cancer	0.000185	0.00167	CcSEcCtD
Flurbiprofen—Pneumonia—Methotrexate—esophageal cancer	0.000184	0.00166	CcSEcCtD
Flurbiprofen—Drowsiness—Methotrexate—esophageal cancer	0.000183	0.00165	CcSEcCtD
Flurbiprofen—Pain—Cisplatin—esophageal cancer	0.000182	0.00164	CcSEcCtD
Flurbiprofen—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000182	0.00164	CcSEcCtD
Flurbiprofen—Tremor—Capecitabine—esophageal cancer	0.00018	0.00162	CcSEcCtD
Flurbiprofen—Renal failure—Methotrexate—esophageal cancer	0.00018	0.00162	CcSEcCtD
Flurbiprofen—Stomatitis—Methotrexate—esophageal cancer	0.000179	0.00161	CcSEcCtD
Flurbiprofen—Ill-defined disorder—Capecitabine—esophageal cancer	0.000179	0.00161	CcSEcCtD
Flurbiprofen—Conjunctivitis—Methotrexate—esophageal cancer	0.000178	0.0016	CcSEcCtD
Flurbiprofen—Anaemia—Capecitabine—esophageal cancer	0.000178	0.0016	CcSEcCtD
Flurbiprofen—Sweating—Methotrexate—esophageal cancer	0.000176	0.00158	CcSEcCtD
Flurbiprofen—Feeling abnormal—Cisplatin—esophageal cancer	0.000176	0.00158	CcSEcCtD
Flurbiprofen—Haematuria—Methotrexate—esophageal cancer	0.000175	0.00157	CcSEcCtD
Flurbiprofen—Oxaprozin—PTGS2—esophageal cancer	0.000175	0.0287	CrCbGaD
Flurbiprofen—Salsalate—PTGS2—esophageal cancer	0.000175	0.0287	CrCbGaD
Flurbiprofen—Malaise—Capecitabine—esophageal cancer	0.000174	0.00156	CcSEcCtD
Flurbiprofen—Epistaxis—Methotrexate—esophageal cancer	0.000173	0.00156	CcSEcCtD
Flurbiprofen—Vertigo—Capecitabine—esophageal cancer	0.000173	0.00156	CcSEcCtD
Flurbiprofen—Syncope—Capecitabine—esophageal cancer	0.000173	0.00155	CcSEcCtD
Flurbiprofen—Leukopenia—Capecitabine—esophageal cancer	0.000172	0.00155	CcSEcCtD
Flurbiprofen—Agranulocytosis—Methotrexate—esophageal cancer	0.000171	0.00154	CcSEcCtD
Flurbiprofen—Palpitations—Capecitabine—esophageal cancer	0.00017	0.00153	CcSEcCtD
Flurbiprofen—Loss of consciousness—Capecitabine—esophageal cancer	0.000169	0.00152	CcSEcCtD
Flurbiprofen—Body temperature increased—Cisplatin—esophageal cancer	0.000169	0.00152	CcSEcCtD
Flurbiprofen—Cough—Capecitabine—esophageal cancer	0.000168	0.00151	CcSEcCtD
Flurbiprofen—Suprofen—PTGS2—esophageal cancer	0.000167	0.0276	CrCbGaD
Flurbiprofen—Hypertension—Capecitabine—esophageal cancer	0.000166	0.00149	CcSEcCtD
Flurbiprofen—Haemoglobin—Methotrexate—esophageal cancer	0.000166	0.00149	CcSEcCtD
Flurbiprofen—Hepatitis—Methotrexate—esophageal cancer	0.000165	0.00148	CcSEcCtD
Flurbiprofen—Haemorrhage—Methotrexate—esophageal cancer	0.000165	0.00148	CcSEcCtD
Flurbiprofen—Myalgia—Capecitabine—esophageal cancer	0.000164	0.00147	CcSEcCtD
Flurbiprofen—Pharyngitis—Methotrexate—esophageal cancer	0.000163	0.00147	CcSEcCtD
Flurbiprofen—Anxiety—Capecitabine—esophageal cancer	0.000163	0.00147	CcSEcCtD
Flurbiprofen—Discomfort—Capecitabine—esophageal cancer	0.000162	0.00146	CcSEcCtD
Flurbiprofen—Dry mouth—Capecitabine—esophageal cancer	0.00016	0.00144	CcSEcCtD
Flurbiprofen—Visual impairment—Methotrexate—esophageal cancer	0.000159	0.00143	CcSEcCtD
Flurbiprofen—Confusional state—Capecitabine—esophageal cancer	0.000158	0.00142	CcSEcCtD
Flurbiprofen—Oedema—Capecitabine—esophageal cancer	0.000157	0.00141	CcSEcCtD
Flurbiprofen—Hypersensitivity—Cisplatin—esophageal cancer	0.000157	0.00141	CcSEcCtD
Flurbiprofen—Infection—Capecitabine—esophageal cancer	0.000156	0.0014	CcSEcCtD
Flurbiprofen—Erythema multiforme—Methotrexate—esophageal cancer	0.000156	0.0014	CcSEcCtD
Flurbiprofen—Shock—Capecitabine—esophageal cancer	0.000155	0.00139	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Capecitabine—esophageal cancer	0.000154	0.00138	CcSEcCtD
Flurbiprofen—Tinnitus—Methotrexate—esophageal cancer	0.000154	0.00138	CcSEcCtD
Flurbiprofen—Tachycardia—Capecitabine—esophageal cancer	0.000153	0.00138	CcSEcCtD
Flurbiprofen—Asthenia—Cisplatin—esophageal cancer	0.000153	0.00138	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Capecitabine—esophageal cancer	0.000152	0.00137	CcSEcCtD
Flurbiprofen—Anorexia—Capecitabine—esophageal cancer	0.00015	0.00135	CcSEcCtD
Flurbiprofen—Angiopathy—Methotrexate—esophageal cancer	0.000149	0.00134	CcSEcCtD
Flurbiprofen—Ketoprofen—PTGS1—esophageal cancer	0.000149	0.0245	CrCbGaD
Flurbiprofen—Chills—Methotrexate—esophageal cancer	0.000148	0.00133	CcSEcCtD
Flurbiprofen—Hypotension—Capecitabine—esophageal cancer	0.000147	0.00132	CcSEcCtD
Flurbiprofen—Ibuprofen—PTGS1—esophageal cancer	0.000147	0.0241	CrCbGaD
Flurbiprofen—Diarrhoea—Cisplatin—esophageal cancer	0.000146	0.00131	CcSEcCtD
Flurbiprofen—Alopecia—Methotrexate—esophageal cancer	0.000146	0.00131	CcSEcCtD
Flurbiprofen—Fenoprofen—PTGS2—esophageal cancer	0.000144	0.0238	CrCbGaD
Flurbiprofen—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000143	0.00129	CcSEcCtD
Flurbiprofen—Insomnia—Capecitabine—esophageal cancer	0.000142	0.00128	CcSEcCtD
Flurbiprofen—Paraesthesia—Capecitabine—esophageal cancer	0.000141	0.00127	CcSEcCtD
Flurbiprofen—Dyspnoea—Capecitabine—esophageal cancer	0.00014	0.00126	CcSEcCtD
Flurbiprofen—Dyspepsia—Capecitabine—esophageal cancer	0.000138	0.00124	CcSEcCtD
Flurbiprofen—Decreased appetite—Capecitabine—esophageal cancer	0.000137	0.00123	CcSEcCtD
Flurbiprofen—Vomiting—Cisplatin—esophageal cancer	0.000136	0.00122	CcSEcCtD
Flurbiprofen—Rash—Cisplatin—esophageal cancer	0.000134	0.00121	CcSEcCtD
Flurbiprofen—Constipation—Capecitabine—esophageal cancer	0.000134	0.00121	CcSEcCtD
Flurbiprofen—Pain—Capecitabine—esophageal cancer	0.000134	0.00121	CcSEcCtD
Flurbiprofen—Dermatitis—Cisplatin—esophageal cancer	0.000134	0.00121	CcSEcCtD
Flurbiprofen—Mefenamic acid—PTGS2—esophageal cancer	0.000134	0.022	CrCbGaD
Flurbiprofen—Ill-defined disorder—Methotrexate—esophageal cancer	0.000133	0.0012	CcSEcCtD
Flurbiprofen—Anaemia—Methotrexate—esophageal cancer	0.000132	0.00119	CcSEcCtD
Flurbiprofen—Naproxen—PTGS2—esophageal cancer	0.000131	0.0216	CrCbGaD
Flurbiprofen—Feeling abnormal—Capecitabine—esophageal cancer	0.00013	0.00116	CcSEcCtD
Flurbiprofen—Malaise—Methotrexate—esophageal cancer	0.000129	0.00116	CcSEcCtD
Flurbiprofen—Vertigo—Methotrexate—esophageal cancer	0.000129	0.00116	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000129	0.00116	CcSEcCtD
Flurbiprofen—Leukopenia—Methotrexate—esophageal cancer	0.000128	0.00115	CcSEcCtD
Flurbiprofen—Nausea—Cisplatin—esophageal cancer	0.000127	0.00114	CcSEcCtD
Flurbiprofen—Cough—Methotrexate—esophageal cancer	0.000125	0.00112	CcSEcCtD
Flurbiprofen—Urticaria—Capecitabine—esophageal cancer	0.000125	0.00112	CcSEcCtD
Flurbiprofen—Abdominal pain—Capecitabine—esophageal cancer	0.000124	0.00112	CcSEcCtD
Flurbiprofen—Body temperature increased—Capecitabine—esophageal cancer	0.000124	0.00112	CcSEcCtD
Flurbiprofen—Convulsion—Methotrexate—esophageal cancer	0.000124	0.00112	CcSEcCtD
Flurbiprofen—Myalgia—Methotrexate—esophageal cancer	0.000122	0.0011	CcSEcCtD
Flurbiprofen—Discomfort—Methotrexate—esophageal cancer	0.000121	0.00108	CcSEcCtD
Flurbiprofen—Confusional state—Methotrexate—esophageal cancer	0.000118	0.00106	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Methotrexate—esophageal cancer	0.000117	0.00105	CcSEcCtD
Flurbiprofen—Infection—Methotrexate—esophageal cancer	0.000116	0.00104	CcSEcCtD
Flurbiprofen—Hypersensitivity—Capecitabine—esophageal cancer	0.000116	0.00104	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Methotrexate—esophageal cancer	0.000115	0.00103	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Methotrexate—esophageal cancer	0.000113	0.00102	CcSEcCtD
Flurbiprofen—Asthenia—Capecitabine—esophageal cancer	0.000113	0.00101	CcSEcCtD
Flurbiprofen—Anorexia—Methotrexate—esophageal cancer	0.000112	0.001	CcSEcCtD
Flurbiprofen—Pruritus—Capecitabine—esophageal cancer	0.000111	0.001	CcSEcCtD
Flurbiprofen—Hypotension—Methotrexate—esophageal cancer	0.000109	0.000983	CcSEcCtD
Flurbiprofen—Diarrhoea—Capecitabine—esophageal cancer	0.000108	0.000967	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000107	0.000958	CcSEcCtD
Flurbiprofen—Insomnia—Methotrexate—esophageal cancer	0.000106	0.000951	CcSEcCtD
Flurbiprofen—Paraesthesia—Methotrexate—esophageal cancer	0.000105	0.000944	CcSEcCtD
Flurbiprofen—Dyspnoea—Methotrexate—esophageal cancer	0.000104	0.000938	CcSEcCtD
Flurbiprofen—Somnolence—Methotrexate—esophageal cancer	0.000104	0.000935	CcSEcCtD
Flurbiprofen—Dizziness—Capecitabine—esophageal cancer	0.000104	0.000934	CcSEcCtD
Flurbiprofen—Dyspepsia—Methotrexate—esophageal cancer	0.000103	0.000926	CcSEcCtD
Flurbiprofen—Decreased appetite—Methotrexate—esophageal cancer	0.000102	0.000914	CcSEcCtD
Flurbiprofen—Pain—Methotrexate—esophageal cancer	0.0001	0.000899	CcSEcCtD
Flurbiprofen—Vomiting—Capecitabine—esophageal cancer	9.99e-05	0.000898	CcSEcCtD
Flurbiprofen—Rash—Capecitabine—esophageal cancer	9.91e-05	0.000891	CcSEcCtD
Flurbiprofen—Dermatitis—Capecitabine—esophageal cancer	9.9e-05	0.00089	CcSEcCtD
Flurbiprofen—Headache—Capecitabine—esophageal cancer	9.85e-05	0.000885	CcSEcCtD
Flurbiprofen—Feeling abnormal—Methotrexate—esophageal cancer	9.64e-05	0.000867	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Methotrexate—esophageal cancer	9.57e-05	0.00086	CcSEcCtD
Flurbiprofen—Nausea—Capecitabine—esophageal cancer	9.33e-05	0.000839	CcSEcCtD
Flurbiprofen—Urticaria—Methotrexate—esophageal cancer	9.29e-05	0.000836	CcSEcCtD
Flurbiprofen—Body temperature increased—Methotrexate—esophageal cancer	9.25e-05	0.000831	CcSEcCtD
Flurbiprofen—Abdominal pain—Methotrexate—esophageal cancer	9.25e-05	0.000831	CcSEcCtD
Flurbiprofen—Diazepam—PTGS1—esophageal cancer	8.98e-05	0.0148	CrCbGaD
Flurbiprofen—Hypersensitivity—Methotrexate—esophageal cancer	8.62e-05	0.000775	CcSEcCtD
Flurbiprofen—Ketoprofen—PTGS2—esophageal cancer	8.51e-05	0.014	CrCbGaD
Flurbiprofen—Asthenia—Methotrexate—esophageal cancer	8.39e-05	0.000755	CcSEcCtD
Flurbiprofen—Ibuprofen—PTGS2—esophageal cancer	8.38e-05	0.0138	CrCbGaD
Flurbiprofen—Pruritus—Methotrexate—esophageal cancer	8.28e-05	0.000744	CcSEcCtD
Flurbiprofen—Diarrhoea—Methotrexate—esophageal cancer	8e-05	0.00072	CcSEcCtD
Flurbiprofen—Dizziness—Methotrexate—esophageal cancer	7.74e-05	0.000696	CcSEcCtD
Flurbiprofen—Vomiting—Methotrexate—esophageal cancer	7.44e-05	0.000669	CcSEcCtD
Flurbiprofen—Rash—Methotrexate—esophageal cancer	7.38e-05	0.000663	CcSEcCtD
Flurbiprofen—Dermatitis—Methotrexate—esophageal cancer	7.37e-05	0.000663	CcSEcCtD
Flurbiprofen—Headache—Methotrexate—esophageal cancer	7.33e-05	0.000659	CcSEcCtD
Flurbiprofen—Ibuprofen—ABCB1—esophageal cancer	7.13e-05	0.0117	CrCbGaD
Flurbiprofen—Nausea—Methotrexate—esophageal cancer	6.95e-05	0.000625	CcSEcCtD
Flurbiprofen—Nitrazepam—ABCB1—esophageal cancer	6.18e-05	0.0102	CrCbGaD
Flurbiprofen—Diazepam—ABCB1—esophageal cancer	4.36e-05	0.00719	CrCbGaD
Flurbiprofen—UGT1A3—Metabolism—CYP1B1—esophageal cancer	2.46e-05	0.000205	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PSME1—esophageal cancer	2.42e-05	0.000202	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PSME2—esophageal cancer	2.42e-05	0.000202	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	2.42e-05	0.000202	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—CYP26A1—esophageal cancer	2.41e-05	0.000201	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	2.41e-05	0.000201	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—GNG7—esophageal cancer	2.39e-05	0.0002	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—GNG7—esophageal cancer	2.39e-05	0.0002	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—NOS3—esophageal cancer	2.39e-05	0.000199	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—ALOX15—esophageal cancer	2.35e-05	0.000196	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	2.35e-05	0.000196	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PLCE1—esophageal cancer	2.35e-05	0.000196	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—ADH7—esophageal cancer	2.35e-05	0.000196	CbGpPWpGaD
Flurbiprofen—PTGS2—Spinal Cord Injury—TP53—esophageal cancer	2.33e-05	0.000195	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	2.33e-05	0.000194	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.32e-05	0.000194	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—CYP19A1—esophageal cancer	2.31e-05	0.000193	CbGpPWpGaD
Flurbiprofen—ABCC4—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.31e-05	0.000193	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—NOS3—esophageal cancer	2.26e-05	0.000189	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—TPI1—esophageal cancer	2.24e-05	0.000187	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—ALDH2—esophageal cancer	2.24e-05	0.000187	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—GSTO1—esophageal cancer	2.24e-05	0.000187	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—ALDH2—esophageal cancer	2.24e-05	0.000187	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—SLC10A2—esophageal cancer	2.24e-05	0.000186	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CA1—esophageal cancer	2.24e-05	0.000186	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	2.22e-05	0.000185	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—ELMO1—esophageal cancer	2.18e-05	0.000181	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—SLC52A3—esophageal cancer	2.15e-05	0.000179	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—BLVRB—esophageal cancer	2.15e-05	0.000179	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—ALDOB—esophageal cancer	2.15e-05	0.000179	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—GSTT1—esophageal cancer	2.13e-05	0.000178	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—GSTT1—esophageal cancer	2.13e-05	0.000178	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—GSTO1—esophageal cancer	2.13e-05	0.000177	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—TPI1—esophageal cancer	2.13e-05	0.000177	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—HMOX1—esophageal cancer	2.11e-05	0.000176	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—CYP2A6—esophageal cancer	2.11e-05	0.000176	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—CYP2A6—esophageal cancer	2.11e-05	0.000176	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.1e-05	0.000175	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—CYP1B1—esophageal cancer	2.09e-05	0.000174	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—GAPDH—esophageal cancer	2.07e-05	0.000173	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—PTGS2—esophageal cancer	2.07e-05	0.000173	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—ADH1B—esophageal cancer	2.06e-05	0.000172	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—CRABP1—esophageal cancer	2.05e-05	0.000171	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CA2—esophageal cancer	2.04e-05	0.000171	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—ALDOB—esophageal cancer	2.04e-05	0.00017	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—ABCB1—esophageal cancer	2.03e-05	0.000169	CbGpPWpGaD
Flurbiprofen—SLC22A6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.01e-05	0.000168	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PTGS1—esophageal cancer	2e-05	0.000167	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PTGS1—esophageal cancer	2e-05	0.000167	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—ENO1—esophageal cancer	2e-05	0.000167	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—ENO1—esophageal cancer	2e-05	0.000167	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2e-05	0.000167	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PSME2—esophageal cancer	1.97e-05	0.000164	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PSME1—esophageal cancer	1.97e-05	0.000164	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PSME1—esophageal cancer	1.97e-05	0.000164	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PSME2—esophageal cancer	1.97e-05	0.000164	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—TYMP—esophageal cancer	1.97e-05	0.000164	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—CYP19A1—esophageal cancer	1.97e-05	0.000164	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—GAPDH—esophageal cancer	1.96e-05	0.000164	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—HIST1H2BM—esophageal cancer	1.96e-05	0.000164	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—GNG7—esophageal cancer	1.95e-05	0.000163	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	1.93e-05	0.000161	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	1.92e-05	0.00016	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CYP26A1—esophageal cancer	1.92e-05	0.00016	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—ADH7—esophageal cancer	1.9e-05	0.000159	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PLCE1—esophageal cancer	1.9e-05	0.000159	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	1.89e-05	0.000158	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.88e-05	0.000157	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—ALOX15—esophageal cancer	1.87e-05	0.000156	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—ABL1—esophageal cancer	1.87e-05	0.000156	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CA1—esophageal cancer	1.83e-05	0.000153	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—SLC10A2—esophageal cancer	1.83e-05	0.000153	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—ALDH2—esophageal cancer	1.83e-05	0.000152	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—EP300—esophageal cancer	1.82e-05	0.000152	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—HMOX1—esophageal cancer	1.79e-05	0.00015	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—GSTO1—esophageal cancer	1.78e-05	0.000148	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—TPI1—esophageal cancer	1.78e-05	0.000148	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—GSTT1—esophageal cancer	1.74e-05	0.000145	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—XIAP—esophageal cancer	1.73e-05	0.000145	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—ABCB1—esophageal cancer	1.72e-05	0.000144	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—EP300—esophageal cancer	1.72e-05	0.000144	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.72e-05	0.000143	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—CYP2A6—esophageal cancer	1.72e-05	0.000143	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.71e-05	0.000143	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—ALDOB—esophageal cancer	1.71e-05	0.000142	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—CYP1B1—esophageal cancer	1.7e-05	0.000142	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—CYP1B1—esophageal cancer	1.7e-05	0.000142	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CA2—esophageal cancer	1.67e-05	0.00014	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—ADH1B—esophageal cancer	1.67e-05	0.000139	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—GAPDH—esophageal cancer	1.64e-05	0.000137	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	1.64e-05	0.000137	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.64e-05	0.000136	CbGpPWpGaD
Flurbiprofen—ALB—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.63e-05	0.000136	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—ENO1—esophageal cancer	1.63e-05	0.000136	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CRABP1—esophageal cancer	1.63e-05	0.000136	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—B2M—esophageal cancer	1.61e-05	0.000134	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PSME2—esophageal cancer	1.61e-05	0.000134	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PSME1—esophageal cancer	1.61e-05	0.000134	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—CYP19A1—esophageal cancer	1.6e-05	0.000133	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—CYP19A1—esophageal cancer	1.6e-05	0.000133	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—TYMP—esophageal cancer	1.59e-05	0.000133	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	1.59e-05	0.000132	CbGpPWpGaD
Flurbiprofen—ALB—Transmembrane transport of small molecules—ABCB1—esophageal cancer	1.56e-05	0.00013	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PLCE1—esophageal cancer	1.56e-05	0.00013	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ADH7—esophageal cancer	1.56e-05	0.00013	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CYP26A1—esophageal cancer	1.55e-05	0.000129	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—GNG7—esophageal cancer	1.55e-05	0.000129	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—ENO1—esophageal cancer	1.54e-05	0.000129	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.54e-05	0.000128	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PSME2—esophageal cancer	1.52e-05	0.000127	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PSME1—esophageal cancer	1.52e-05	0.000127	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—ALOX15—esophageal cancer	1.51e-05	0.000126	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CALR—esophageal cancer	1.46e-05	0.000122	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—HMOX1—esophageal cancer	1.46e-05	0.000122	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—HMOX1—esophageal cancer	1.46e-05	0.000122	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—ALDH2—esophageal cancer	1.45e-05	0.000121	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—TPI1—esophageal cancer	1.44e-05	0.00012	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—GSTO1—esophageal cancer	1.44e-05	0.00012	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.43e-05	0.000119	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—FBXW7—esophageal cancer	1.41e-05	0.000118	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.4e-05	0.000117	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—ABCB1—esophageal cancer	1.4e-05	0.000117	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—ABCB1—esophageal cancer	1.4e-05	0.000117	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—CYP1B1—esophageal cancer	1.39e-05	0.000116	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—ALDOB—esophageal cancer	1.38e-05	0.000115	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—GSTT1—esophageal cancer	1.38e-05	0.000115	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CYP2A6—esophageal cancer	1.36e-05	0.000114	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ADH1B—esophageal cancer	1.36e-05	0.000114	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.36e-05	0.000113	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—CREBBP—esophageal cancer	1.35e-05	0.000113	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—NOS2—esophageal cancer	1.35e-05	0.000112	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—PIK3CA—esophageal cancer	1.35e-05	0.000112	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—GAPDH—esophageal cancer	1.33e-05	0.000111	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CRABP1—esophageal cancer	1.32e-05	0.00011	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—TYMP—esophageal cancer	1.3e-05	0.000109	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—CYP19A1—esophageal cancer	1.3e-05	0.000109	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—TP53—esophageal cancer	1.3e-05	0.000109	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—ENO1—esophageal cancer	1.29e-05	0.000108	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PTGS1—esophageal cancer	1.29e-05	0.000108	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PSME2—esophageal cancer	1.27e-05	0.000106	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PSME1—esophageal cancer	1.27e-05	0.000106	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—PIK3CA—esophageal cancer	1.27e-05	0.000106	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CYP26A1—esophageal cancer	1.27e-05	0.000106	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—GNG7—esophageal cancer	1.25e-05	0.000105	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ALOX15—esophageal cancer	1.24e-05	0.000103	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—NOS3—esophageal cancer	1.21e-05	0.000101	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—CREBBP—esophageal cancer	1.21e-05	0.000101	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—HMOX1—esophageal cancer	1.19e-05	9.92e-05	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	1.18e-05	9.85e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—TPI1—esophageal cancer	1.18e-05	9.83e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GSTO1—esophageal cancer	1.18e-05	9.83e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—ALDH2—esophageal cancer	1.17e-05	9.79e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.17e-05	9.73e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—CREBBP—esophageal cancer	1.15e-05	9.6e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—TGFBR2—esophageal cancer	1.14e-05	9.53e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—ABCB1—esophageal cancer	1.14e-05	9.52e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ALDOB—esophageal cancer	1.13e-05	9.43e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—GSTT1—esophageal cancer	1.12e-05	9.32e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PTGS2—esophageal cancer	1.11e-05	9.25e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CYP2A6—esophageal cancer	1.1e-05	9.21e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CYP1B1—esophageal cancer	1.1e-05	9.17e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.1e-05	9.17e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GAPDH—esophageal cancer	1.09e-05	9.08e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—SMAD4—esophageal cancer	1.08e-05	9.02e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—NOS3—esophageal cancer	1.08e-05	9.02e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CRABP1—esophageal cancer	1.08e-05	8.99e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.06e-05	8.83e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PTGS1—esophageal cancer	1.05e-05	8.73e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—ENO1—esophageal cancer	1.05e-05	8.73e-05	CbGpPWpGaD
Flurbiprofen—ALB—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.05e-05	8.72e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CYP19A1—esophageal cancer	1.03e-05	8.63e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PSME2—esophageal cancer	1.03e-05	8.6e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PSME1—esophageal cancer	1.03e-05	8.6e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—NOS3—esophageal cancer	1.03e-05	8.6e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GNG7—esophageal cancer	1.03e-05	8.55e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ALDH2—esophageal cancer	9.61e-06	8.02e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—HMOX1—esophageal cancer	9.44e-06	7.87e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PTGS2—esophageal cancer	9.43e-06	7.86e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—CREBBP—esophageal cancer	9.36e-06	7.8e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—CREBBP—esophageal cancer	9.36e-06	7.8e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.26e-06	7.72e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—EP300—esophageal cancer	9.22e-06	7.69e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GSTT1—esophageal cancer	9.14e-06	7.62e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—ABCB1—esophageal cancer	9.06e-06	7.55e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CYP2A6—esophageal cancer	9.04e-06	7.54e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	9.01e-06	7.51e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	9e-06	7.51e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CYP1B1—esophageal cancer	8.9e-06	7.42e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—HIF1A—esophageal cancer	8.85e-06	7.38e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	8.63e-06	7.2e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PTGS1—esophageal cancer	8.57e-06	7.15e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ENO1—esophageal cancer	8.57e-06	7.15e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PSME2—esophageal cancer	8.44e-06	7.04e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PSME1—esophageal cancer	8.44e-06	7.04e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—NOS3—esophageal cancer	8.38e-06	6.99e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—NOS3—esophageal cancer	8.38e-06	6.99e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CYP19A1—esophageal cancer	8.37e-06	6.98e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—EP300—esophageal cancer	8.23e-06	6.86e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—NOS2—esophageal cancer	8.05e-06	6.71e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—NOTCH1—esophageal cancer	7.97e-06	6.65e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—EP300—esophageal cancer	7.84e-06	6.54e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PTGS2—esophageal cancer	7.66e-06	6.39e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PTGS2—esophageal cancer	7.66e-06	6.39e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—HMOX1—esophageal cancer	7.64e-06	6.37e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—CREBBP—esophageal cancer	7.63e-06	6.36e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	7.49e-06	6.25e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.37e-06	6.15e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—ABCB1—esophageal cancer	7.33e-06	6.11e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CYP1B1—esophageal cancer	7.28e-06	6.08e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CREBBP—esophageal cancer	7.23e-06	6.03e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CYP19A1—esophageal cancer	6.85e-06	5.71e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.85e-06	5.71e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—NOS3—esophageal cancer	6.83e-06	5.69e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PIK3CA—esophageal cancer	6.82e-06	5.69e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—NOS3—esophageal cancer	6.47e-06	5.4e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—EP300—esophageal cancer	6.37e-06	5.31e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—EP300—esophageal cancer	6.37e-06	5.31e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—HMOX1—esophageal cancer	6.25e-06	5.21e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PTGS2—esophageal cancer	6.25e-06	5.21e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.13e-06	5.11e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—PIK3CA—esophageal cancer	6.09e-06	5.08e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CREBBP—esophageal cancer	6.05e-06	5.05e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—ERBB2—esophageal cancer	6.05e-06	5.05e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ABCB1—esophageal cancer	6e-06	5e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—TP53—esophageal cancer	5.89e-06	4.91e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PIK3CA—esophageal cancer	5.8e-06	4.84e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.54e-06	4.62e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—NOS3—esophageal cancer	5.42e-06	4.52e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—EP300—esophageal cancer	5.19e-06	4.33e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CDKN1A—esophageal cancer	5.17e-06	4.32e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—EP300—esophageal cancer	4.92e-06	4.11e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CREBBP—esophageal cancer	4.9e-06	4.09e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PIK3CA—esophageal cancer	4.71e-06	3.93e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PIK3CA—esophageal cancer	4.71e-06	3.93e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.54e-06	3.78e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—NOS3—esophageal cancer	4.39e-06	3.66e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—MYC—esophageal cancer	4.29e-06	3.58e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—EGFR—esophageal cancer	4.2e-06	3.5e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—EP300—esophageal cancer	4.12e-06	3.44e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PTGS2—esophageal cancer	4.01e-06	3.35e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CREBBP—esophageal cancer	4.01e-06	3.34e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PIK3CA—esophageal cancer	3.84e-06	3.2e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PIK3CA—esophageal cancer	3.64e-06	3.04e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—NOS3—esophageal cancer	3.59e-06	2.99e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—EP300—esophageal cancer	3.34e-06	2.78e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PTGS2—esophageal cancer	3.28e-06	2.74e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PIK3CA—esophageal cancer	3.05e-06	2.54e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—EP300—esophageal cancer	2.73e-06	2.28e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PIK3CA—esophageal cancer	2.47e-06	2.06e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PIK3CA—esophageal cancer	2.02e-06	1.68e-05	CbGpPWpGaD
